Bridgeway Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-7,400
| Closed | -$1.53M | – | 1276 |
|
|
2024
Q2 | $1.53M | Sell |
7,400
-20,850
| -74% | -$4.31M | 0.04% | 579 |
|
|
2024
Q1 | $7.65M | Sell |
28,250
-15,300
| -35% | -$4.15M | 0.16% | 195 |
|
|
2023
Q4 | $10.3M | Sell |
43,550
-1,750
| -4% | -$414K | 0.22% | 129 |
|
|
2023
Q3 | $8.88M | Sell |
45,300
-8,075
| -15% | -$1.58M | 0.22% | 133 |
|
|
2023
Q2 | $11.2M | Sell |
53,375
-4,000
| -7% | -$841K | 0.27% | 90 |
|
|
2023
Q1 | $11.6M | Sell |
57,375
-6,900
| -11% | -$1.39M | 0.31% | 63 |
|
|
2022
Q4 | $14M | Buy |
64,275
+2,925
| +5% | +$637K | 0.36% | 35 |
|
|
2022
Q3 | $12.1M | Sell |
61,350
-24,750
| -29% | -$4.87M | 0.32% | 48 |
|
|
2022
Q2 | $18.4M | Buy |
+86,100
| New | +$18.4M | 0.42% | 16 |
|